Singular Genomics Systems Statistics Share Statistics Singular Genomics Systems has 2.54M
shares outstanding. The number of shares has increased by 1.66%
in one year.
Shares Outstanding 2.54M Shares Change (YoY) 1.66% Shares Change (QoQ) 0% Owned by Institutions (%) 34.51% Shares Floating 1.84M Failed to Deliver (FTD) Shares 26 FTD / Avg. Volume 0.19%
Short Selling Information The latest short interest is 45.72K, so 0% of the outstanding
shares have been sold short.
Short Interest 45.72K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 6.84
Valuation Ratios The PE ratio is -0.35 and the forward
PE ratio is -0.9.
Singular Genomics Systems's PEG ratio is
-0.07.
PE Ratio -0.35 Forward PE -0.9 PS Ratio 11.5 Forward PS 1.6 PB Ratio 0.19 P/FCF Ratio -0.45 PEG Ratio -0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Singular Genomics Systems.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.51,
with a Debt / Equity ratio of 0.42.
Current Ratio 10.51 Quick Ratio 9.77 Debt / Equity 0.42 Debt / EBITDA -0.87 Debt / FCF -1.01 Interest Coverage -93.37
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $11.42K Profits Per Employee $-371.84K Employee Count 255 Asset Turnover 0.01 Inventory Turnover 0.26
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 181.04% in the
last 52 weeks. The beta is 1.83, so Singular Genomics Systems's
price volatility has been higher than the market average.
Beta 1.83 52-Week Price Change 181.04% 50-Day Moving Average 19.81 200-Day Moving Average 14.23 Relative Strength Index (RSI) 56.73 Average Volume (20 Days) 13,411
Income Statement In the last 12 months, Singular Genomics Systems had revenue of 2.91M
and earned -94.82M
in profits. Earnings per share was -39.08.
Revenue 2.91M Gross Profit -558K Operating Income -102.8M Net Income -94.82M EBITDA -86.5M EBIT -93.72M Earnings Per Share (EPS) -39.08
Full Income Statement Balance Sheet The company has 16.23M in cash and 75.29M in
debt, giving a net cash position of -59.05M.
Cash & Cash Equivalents 16.23M Total Debt 75.29M Net Cash -59.05M Retained Earnings -337.6M Total Assets 186.55M Working Capital 112.2M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -73.65M
and capital expenditures -970K, giving a free cash flow of -74.62M.
Operating Cash Flow -73.65M Capital Expenditures -970K Free Cash Flow -74.62M FCF Per Share -30.75
Full Cash Flow Statement Margins Gross margin is -19.17%, with operating and profit margins of -3531.47% and -3257.3%.
Gross Margin -19.17% Operating Margin -3531.47% Pretax Margin -3257.3% Profit Margin -3257.3% EBITDA Margin -2971.35% EBIT Margin -3531.47% FCF Margin -2563.28%
Dividends & Yields OMIC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for OMIC is $6.5,
which is -67.5% lower than the current price. The consensus rating is "Hold".
Price Target $6.5 Price Target Difference -67.5% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 26, 2024. It was a
backward
split with a ratio of 1:30.
Last Split Date Jun 26, 2024 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -3.3 Piotroski F-Score 3
